PharmaShots | Incisive News in 3 Shots

Subscribe Now

Lexeo Therapeutics

Lexeo Therapeutics Reports Interim Data from P-I/II Study of LX2006 to Treat Friedreich Ataxia Cardiomyopathy

Lexeo Therapeutics Reports Interim Data from P-I/II Study of LX2006 to Treat Friedreich Ataxia Cardiomyopathy

July 15, 2024

LEXEO Therapeutics Reports the Completion of First Cohort and Dosing in Second Cohort in P-I/II Trial (SUNRISE-FA) of LX2006 for Friedreich’s Ataxia Cardiomyopathy

LEXEO Therapeutics Reports the Completion of First Cohort and Dosing in Second Cohort in P-I/II Trial (SUNRISE-FA) of LX2006 for F...

June 15, 2023

PharmaShots Weekly Snapshots (April 19 - 23, 2021)

PharmaShots Weekly Snapshots (April 19 - 23, 2021)

April 23, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us